# Invado Pharmaceuticals

- Location (FDA's records): Pomona, NY
- FDA decisions: 2 (2009–2015): 2 510(k) clearances
- Product codes: FRO (1), LFD (1)
- Predicates its devices cite: 6 (0 its own); citations of its devices by later devices: 1 (0 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- Inpharma A.S.: 2 (https://510kreport.com/company/inpharma)
- Stratus Pharmaceutical: 1 (https://510kreport.com/company/stratus-pharmaceutical)
- Stiefel Laboratories, Inc.: 1 (https://510kreport.com/company/stiefel-laboratories)
- Prugen, Inc.: 1 (https://510kreport.com/company/prugen)
- Bartor Pharmacal Co., Inc.: 1 (https://510kreport.com/company/bartor-pharmacal)

## Firms that cite its devices most
- Forward Science, LLC: 1 (https://510kreport.com/company/forward-science)

## Its most-cited devices
- K093642: Neutrasal (2009), cited by 1

## Recent decisions
- K140905: Dermafine (May 8, 2015)
- K093642: Neutrasal (Dec 11, 2009)

Source page: https://510kreport.com/company/invado-pharmaceuticals
